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Abstract
In this study, a whole-genome CombiMatrix Custom oligonucleotide tiling microarray with 90000 probes covering six
sequenced Helicobacter pylori (H. pylori) genomes was designed. This microarray was used to compare the genomic profiles
of eight unsequenced strains isolated from patients with different gastroduodenal diseases in Heilongjiang province of
China. Since significant genomic variation was found among these strains, an additional 76 H. pylori strains associated with
different clinical outcomes were isolated from various provinces of China. These strains were tested by polymerase chain
reaction to demonstrate this distinction. We identified several highly variable regions in strains associated with gastritis,
gastric ulceration, and gastric cancer. These regions are associated with genes involved in the bacterial type I, type II, and
type III R-M systems. They were also associated with the virB gene, which lies on the well-studied cag pathogenic island.
While previous studies have reported on the diverse genetic characterization of this pathogenic island, in this study, we find
that it is conserved in all strains tested by microarray. Moreover, a number of genes involved in the type IV secretion system,
which is related to horizontal DNA transfer between H. pylori strains, were identified in the comparative analysis of the
strain-specific genes. These findings may provide insight into new biomarkers for the prediction of gastric diseases.
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Introduction
Helicobacter pylori (H. pylori) is a Gram-negative bacterial patho-
gen responsible for human gastric diseases, including gastritis and
peptic ulcers. It is also a major risk factor in the development of
gastric cancer [1–3]. In 1994, the World Health Organization
listed H. pylori as a class I carcinogen.
Previous studies have shown that H. pylori has a high rate of
homologous gene recombination. Phylogenetic analysis have
subdivided H. pylori into distinct biogeographic populations and
subpopulations with specific geographical distributions that reflect
ancient human migrations. The studies also indicated that the East
Asian type (hpEastAsia) is classified into at least three subtypes:
East Asian (hspEAsia), Pacific (hspMaori) and native American
(hspAmerind). The East Asia subtype (hspEAsia) may be related to
the high incidence of gastric cancer in East Asia [4–7]. A more
recent study demonstrate the East Asian group appear to differ
greatly from the European group in electron transfer and redox
reactions, which suggest a model of adaptive evolution and
selection through proteome diversification and modulation of
translational fidelity [8].
A number of studies have focused on the cag- pathogenicity
island encoded virulence apparatus that may play a critical role in
H. pylori pathogenesis [9–11]. Importantly, almost all isolates from
East Asia harbor the cag-PAI island. A few studies have shown that
there are specific sequence characteristics shared among these
islands in the various strains, which are responsible for causing
different diseases [12–14]. This suggests that genome-wide
analyses in various worldwide strains, especially for strains found
in East Asia, are necessary. To date, there are thirty-two
completed genomes and four draft genomes available on GenBank
[15–27]. Genome sizes among clinical isolates of H. pylori vary
considerably, with some showing differences up to 25% [28,29].
Comparative genomic profiling, using microarrays designed to
cover entire genomes, is one strategy that can be used to obtain
information about the variability between strains isolated from
different patients and locations as well as to indicate horizontal
gene transfer. Previously available commercial chips cover only
one or two H. pylori genomes [30–37]. With more H. pylori genome
sequences publicly available, it is possible to design high-density
microarrays covering all of these fully sequenced genomes. During
this study, an additional twenty-six strains associated with different
clinical outcomes of various phylogeographic lineages were
completely sequenced in the last two years. Additionally, several
strains from other countries are also now undergoing sequencing.
Here we describe the design and use of a high-density
oligonucleotide microarray covering six sequenced H. pylori
genomes. The performance of this microarray is evaluated, and
we illustrate its utility for the hybridization of genomic DNA in
order to compare eight uncharacterized H. pylori strains to the six
established strains. We use this microarray to identify variable
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38528genomic regions among H. pylori strains isolated from patients with
different gastroduodenal diseases in a Chinese patient population.
Materials and Methods
H. Pylori Strains
H. pylori is a well-known pathogen with much genetic variation;
both host and bacterial factors may contribute to this fact. Strains
isolated from different countries, different geographies, and even
different families show genomic diversity [38]. Therefore, from a
genomic viewpoint, strain selection has been a critical issue for
investigation of the pathogenic mechanism. In this study, we chose
eight strains for microarray analysis. This included isolates from 2
patients with chronic superficial gastritis (HLJ220,HLJ215), 2
patients with atrophic gastritis (HLJ193,HLJ256), 2 patients with
gastric ulcers (HLJ271,HLJ253), and 2 patients with gastric cancer
(HLJ038,HLJ005). The strain numbers were encoded by our lab,
Department of Diagnosis for Communicable Diseases, National
Institute for Communicable Disease Control and Prevention,
China CDC. They were all isolated from Heilongjiang province of
China, which reports a high incidence rate of gastric cancer. We
used PCR for investigating an additional 76 strains of disease
specific genes, which were isolated from seven Chinese provinces.
These included thirty-one gastric cancer strains (GC), six gastric
ulcer strains (GU), one atrophic gastritis strain (AG), eight
duodenal ulcer strains (DU), three gastroduodenal ulcer strains
(GDU), six functional dyspesia strains (FD), and twenty-one non-
atrophic gastritis strains (SG). Background information describing
these strains is briefly listed in table 1.
Ethics Statement
All patients involved have given informed consent for the
samples to be used in historic or future studies. The consent was
written, and ethics approval was obtained from the ethics
committee of the Chinese Center for Disease Control and
Prevention (China CDC) and the academic committee of the
National Institute for Communicable Disease Control and
Prevention, China CDC.
DNA Preparation
Genomic DNA was extracted by using the DNeasy Blood &
Tissue Kit (QIAGEN) according to the manufacturer’s instruc-
tions. The concentration of genomic DNA was adjusted to 120
ng/ml with nuclease-free water and to a volume of 40 ml. DNA was
heated in a PCR machine (Biorad, USA) at 95uC for 10 min to
obtain DNA fragments with sizes of 100 bp to 600 bp for genomic
labeling. The results were visualized by 1% agarose gel
electrophoresis.
Microarray Design, Labeling, Hybridization and Stripping
A whole-genome CombiMatrix tiling CustomArray
TM 90 K
(Mukilteo, WA, USA) was used in this study. Combimatrix is a
highly flexible platform that allows for the synthesis of in situ oligos
(35mers) through the use of an electrochemistry-based method.
This innovative technology also allows us to reuse the same
microarray several times. Traditional cDNA microarrays involve
large amounts of primer design and PCR for preparation of
amplicon probes to be used for microarray printing. This process
can be cumbersome and time consuming. Compared to all other
platforms, including cDNA microarray, the Combimatrix drasti-
cally reduces fabrication and analytic costs. Thus, this process is
more rapid and convenient. The platform has established a
complete protocol for genomic analyses from sample labeling to
data extraction [39–41].The array contained 90000 in situ
synthesized oligonucleotide probes. In total, six sequenced
genomes were taken for analysis. Genomic information for each
strain is summarized in Table 2. Genome alignments were
performed by Combimatrix to obtain strain specific genes of each
sequenced strain. We then took the whole genome of P12 as the
reference sequence for tiling designation, which occupied about
70000 probes on the 90 k array. The sequences were first broken
up into 100,000 bp blocks. We designed all possible probes for
every 19 bp and selected the best one for each interval. At each
position, a probe was extended until the Tm reached the desired
Tm. Probes were then tested for quality, and the best probe (probe
length 35,40 mer) was chosen. Both strain-specific genes and
plasmid genes were then chosen for tiling for the remaining 20000
probes based on the same criteria.
Four micrograms of heated DNA from each H. pylori strain was
labeled with Cy5-ULS using the Kreatech ULS array CGH
Labeling kit (EA-005, Kreatech, Netherlands) according to the
manufacturer’s instructions and then hybridized to the micro-
Table 1. Characteristics of the 84 H. pylori strains studied.
Origin Clinical Diagnosis No. of strains
Heilongjiang (n=23) GC 12
DU 3
GU 3
AG 3
SG 2
Shandong (n=12) GC 12
Hubei (n=10) FD 6
GU 2
DU 2
Xi’an (n=11) SG 7
DU 1
GDU 3
Yunnan (n=10) SG 5
GU 3
DU 2
Jiangxi (n=18) SG 9
GC 9
Note: GC, gastric cancer. GU, gastric ulcer. AG, atrophic gastritis, DU, duodenal
ulcer, GDU, gastroduodenal ulcer. FD, functional dyspepsia. SG, non-atrophic
gastritis.
doi:10.1371/journal.pone.0038528.t001
Table 2. General features of the sequenced H. pylori
genomes selected for microarray probe design.
strain ACCESSION length origin Clinical diagnosis
26695 AE000511 1667867 UK Gastritis
J99 AE001439 1643831 USA Duodenal ulcer
HPAG1 CP000241 1596366 Sweden Atrophic gastritis
P12 CP001217 1673813 German Duodenal ulcer
G27 CP001173 1652982 Italy, Tuscany No known disease
Shi470 CP001072 1608548 Peru Gastritis
doi:10.1371/journal.pone.0038528.t002
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protocol. Microarrays were pre-hybridized with 66SSPE contain-
ing 0.05% Tween-20, 56Denhardt’s solution, and 100 ng salmon
sperm DNA for 30 min at 50uC. The Cy5-ULS labeled DNA
fragments were then hybridized in the hybridizing solution
(66SSPE and 0.05% SDS) by denaturing at 95uC for 3 min and
then incubating for 16 h at 50uC. Post-hybridization wash steps
were 66SSPET for 5 min at 50uC, 36SSPET for 1 min,
0.56SSPET for 1 min, and PBST for 1 min at room temperature.
After hybridization and imaging, the microarray was stripped
using CustomArray
TM Stripping Solution. The well known
sequenced strain 26695 and an additional eight strains from
Heilongjiang province were hybridized to the chips.
Microarray Scanning and Statistical Analysis
Hybridized microarrays were covered with imaging solution
and scanned with an Axon GenePix
TM 4000B. All of the nine
hybridizations were scanned at the same PMT value. The stripped
microarray was also scanned with the same PMT gain value (475)
to evaluate background noise as well as the stripping efficiency.
Data was extracted by using Microarray_Imager_5.9.3 software.
The foreground median of 635-nm signal intensities of each spot
Figure 1. Comparison of HLJ005, HLJ038, and 26695 based on strain specific genes of the six sequenced genomes. A. Comparison
between HLJ005 and 26695. B. Comparison between HLJ038 and 26695. C. Comparison between HLJ038 and HLJ005. Green spots show inferred loss
while orange dots show no changes in the original data. Red spots show inferred increase. Segment 1 on the X-axis: probes of 26695 strain specific
genes. Segment 2: probes of G27 strain specific genes. Segment 3: probes of HPAG1 strain specific genes. Segment 4: probes of J99 strain specific
genes. Segment 5: probes of P12 strain specific genes. Segment 6: probes of Shi470 strain specific genes.
doi:10.1371/journal.pone.0038528.g001
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B. Comparison between HLJ038 and 26695. C. Comparison between HLJ038 and HLJ005. Green spots show inferred loss while orange dots show no
changes in the original data. Red spots show inferred increase. The red rectangle indicates the predicted 5.2 kb absent region both in gastric cancer
strain HLJ038 and HLJ005 based on the 0–100 kb of the reference P12 chromosome.
doi:10.1371/journal.pone.0038528.g002
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contiguous oligonucleotides with a minimum 635-nm intensity of
800 intensity units, and had at least one tile with 635-nm intensity
.1200 intensity units were defined as positive. We defined
background signal intensity as the median signal intensity of all
spots locations that did not have any oligos. QC-oligoB-AS-3 spots
were also included in the background. QC-oligoB-AS-3 spots were
CombiMatrix quality control oligonucleotides that occur 459
times on the array. Since QC-oligoB-AS-3 does not align to the
H. pylori genome, these spots could be considered for background
calculation for further analysis. On each of the arrays, the
background signal was ,400 intensity units, indicating that our
signal cutoff of 800 was sufficiently above background for
identification. Based on the above described criteria for gene
identification, information of probe location and corresponding
hybridization signals were extracted for further analysis. For ease
of analysis, all genes were separated into two independent files, one
including genes located in the H. pylori P12 genome and another
including strain specific genes in each of the other strains, which
are named chromosome 1–6 (this also included P12 strain specific
genes). Isolates of gastric cancer were represented as GC, isolates
of gastric ulcers were represented as GU, isolates of chronic
superficial gastritis were represented as SG, and isolates of
atrophic gastritis were represented as AG. Signal comparison
was performed between the two strains in GC, GU, SG, and AG.
Comparison was also performed by GC vs GU, GU vs AG, GC vs
SG, and AG vs SG. Signal ratios of two hybridized strains were
log2 transformed and imported into a web tool ADaCGH, which
was used for the analysis of microarray datasets to show gains and
losses of genes between the two genomes. The data was centered
and segmented in ADaCGH by employing a position-dependent
segmentation algorithm CBS (circular binary segmentation) to
partition data points into absent, present, and no change sequence
segments [42,43]. Chi-square was used to analyze the association
of genes with disease by comparing one disease group (i.e., GC)
with the other two groups (i.e., SG and GU), as well as to analyze
the TFSS gene distributions among different disease groups.
P value ,0.05 was considered significant.
Microarray Data Deposition
MIAME compliant microarray data of this study has been
deposited at the Gene Expression Omnibus database (GEO,
http://www.ncbi.nlm.nih.gov/geo/) under series accession num-
ber GSE32107.
Validation of genes associated with diseases by PCR
The results for some variable genes found to be associated with
diseases by microarray analysis were confirmed using gene-specific
Figure 3. Genome comparison of eight H. pylori strains based on P12 reference sequence. Large variable regions were labeled with
colored rectangles. Predicted gastric cancer strain specific regions were labeled with a red rectangle. General genomic variation among all strains was
labeled with a green rectangle. A blue rectangle represents diverse regions obtained from comparison of gastric cancer strains and superficial
gastritis strains. Corresponding coding proteins were briefly labeled at the bottom of each rectangle. GC vs SG denotes comparison between the two
strains of gastric cancer and the two strains of superficial gastritis. DR, different region.
doi:10.1371/journal.pone.0038528.g003
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TFSS systems, a predicted 5.2 kb variable region, and an hrgA
gene, which was reported to have a high occurrence rate in strains
isolated from gastric cancer patients in East Asia. Specific primers
were selected based on the sequences of these genes. To investigate
the distribution of genes that were predicted as genomic distinctive
regions, eighty-four strains were selected for PCR analysis of the
Table 3. Predicted variable genomic region based on
reference genome P12.
DR Gene start end Gene description
DR1 49177 49869 adenine specific DNA methyltransferase
49866 50933 cytosine specific DNA methyltransferase
50930 52153 restriction endonuclease
52297 53568 type II R-M system restriction
endonuclease
53568 56036 type II R-M system methyltransferase
DR2 295040 303760 vacuolating cytotoxin VacA-like protein
DR4 hsdS-1 448002 449183 type I R-M system S protein
hsdM-1 449176 450807 type I R-M system M protein
452423 453496 integrase/recombinase XercD family
453578 454261 hypothetical protein
virb6 454334 455632 VirB6 type IV secretion protein
455598 455876 hypothetical protein
455928 457328 hypothetical protein
457332 457577 hypothetical protein
457791 459272 hypothetical protein
459405 460469 hypothetical protein
460312 460803 hypothetical protein
460810 461832 hypothetical protein
462096 470522 DNA methylase
parA 470785 471441 chromosome partitioning protein
471523 471807 hypothetical protein
471839 473017 hypothetical protein
virD2-1 473042 474955 relaxase
475253 475567 hypothetical protein
475560 475841 hypothetical protein
virD4-1 476105 477832 VirD4 coupling protein
477879 478391 hypothetical protein
478392 478682 hypothetical protein
478679 479134 hypothetical protein
virB11-1 479131 480072 VirB11 type IV secretion ATPase
480072 480371 hypothetical protein
480368 480631 hypothetical protein
480624 480917 hypothetical protein
virB10-1 480987 482252 VirB10 type IV secretion protein
virB9-1 482252 483784 VirB9 type IV secretion protein
virB8-1 483784 484953 VirB8 type IV secretion protein
virB7-1 484957 485073 VirB7 type IV secretion protein
virB3-1 489522 489788 VirB3 type IV secretion protein
virB2-1 489789 490091 VirB2 type IV secretion protein
490088 490372 hypothetical protein
490433 491611 hypothetical protein
491618 491911 hypothetical protein
491931 492710 hypothetical protein
494743 496638 hypothetical protein
496664 497431 hypothetical protein
497441 497791 integral membrane protein
virb6 454334 455632 VirB6 type IV secretion protein
455598 455876 hypothetical protein
Table 3. Cont.
DR Gene start end Gene description
455928 457328 hypothetical protein
457332 457577 hypothetical protein
DR6 res-1 628179 631121 type III R-M system restriction enzyme
DR8 1050977 1051564 serine/threonine kinase C-like protein
1051604 1052053 serine/threonine kinase C-like protein
1052213 1052728 serine/threonine phosphatase 2C-like
protein
DR11 virB2-2 1396323 1396607 VirB2 type IV secretion protein
virB3-2 1396619 1396882 VirB3 type IV secretion protein
1396894 1397130 hypothetical protein
virB4-2 1397130 1399706 VirB4 type IV secretion ATPase
virB7-2 1399703 1399843 VirB7 type IV secretion protein
virB8-2 1399836 1400972 VirB8 type IV secretion protein
virB9-2 1400969 1402624 VirB9 type IV secretion protein
virB10-2 1402591 1403829 VirB10 type IV secretion protein
1403813 1405597 hypothetical protein
1405501 1406055 hypothetical protein
1406068 1407030 hypothetical protein
1407047 1407322 hypothetical protein
virB11-3 1407327 1408271 VirB11 type IV secretion ATPase
1408268 1408786 hypothetical protein
virD4-2 1408783 1411026 VirD4 coupling protein
1413163 1413633 hypothetical protein
1413603 1414406 hypothetical protein
1414480 1415145 hypothetical protein
1415123 1415401 hypothetical protein
1415334 1415765 hypothetical protein
1415750 1416160 hypothetical protein
1416165 1416794 hypothetical protein
1416897 1417178 hypothetical protein
1417399 1417788 hypothetical protein
1417796 1418086 hypothetical protein
1418215 1418466 hypothetical protein
1418394 1419248 hypothetical protein
1421131 1421259 hypothetical protein
virD2-2 1421785 1423818 relaxase
DR12 1575820 1579728 type IIS R-M system
restriction/modification enzyme
1580020 1582023 hypothetical protein
res-4 1582157 1585066 type III R-M system restriction enzyme
mod-5 1585069 1587111 type III R-M system methyltransferase
Note: DR, different region
doi:10.1371/journal.pone.0038528.t003
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Mev_4_0-2.
Results
Microarray Hybridization and Statistical Analysis
In order to test whether the established H. pylori microarray
analysis system can accurately predict genomic distinction, we first
analyzed strains 26695, HLJ005, and HLJ038 based on strain
specific genes and 0–100 kb of the reference P12 genome
sequence. As shown in Figure 1, six segments on the X-axis
represent strain specific genes of the six sequenced genomes.
Probes of segment one are strain specific genes of 26695. When
comparing the hybridization signal of gastric cancer strain HLJ005
to 26695 with the web tool ADaCGH, almost all of these genes
were predicted to be absent in HLJ005 (Figure 1 A). The same
pattern was found in another gastric cancer strain HLJ038
(Figure 1 B).When comparing HLJ005 and HLJ038, only some
minor variable probes were found in the six segments (Figure 1 C).
These analyses indicate that this custom designed microarray
platform accurately predicts gene absence or presence in different
clinical H. pylori isolates. This was further validated by PCR to
confirm a predicted 5.2 kb absent region both in gastric cancer
strain HLJ038 and HLJ005 based on the 0–100 kb of the reference
P12 chromosome (Figure 2).
Variable genes of the tested strains were first obtained based on
the reference P12 genome sequence (Figure 3, Table 3). Twelve
genomic regions with the most variable tiles among the eight
strains are marked by a rectangle. Predicted gastric cancer strain
specific regions were labeled with a red rectangle according to the
comparison of GC vs SG and GC vs GU. Seven such areas were
acquired, and encoded proteins were listed in Table 3 (DR1, 3, 4,
6, 8, 9, 12). The number of these variable genes present in the
group of gastric cancer strains was statistically higher than those
for the GU and SG strains (P,0.05). These regions mainly coded
for proteins related to the type I R-M system, type II R-M system,
type III R-M system, TFSS system, and hypothetical proteins.
General genomic variations among all strains were labeled with a
green rectangle. Seven such regions were identified (DR 1, 2, 4, 5,
7, 8, 11). No significant correlation was found for the unique
absence or presence of TFS4 or TFS3. However, absence of both
TFS3 and TFS4 system genes display significant variation
comparing GC strains to GU, DU, or SG strains (P,0.05).
Among the 25 strains that are absent for these two systems, 17
strains are GC strains (68%). No significant variation was found
for the association of any gene cluster with special geography. In
addition, cagPAI was also labeled with a green rectangle for its
diversity among reported strains (DR5). However, cagPAI were
conserved among the tested strains of this study. The blue
rectangle represents diverse regions obtained from comparison of
gastric cancer strain with superficial gastritis strain (DR10). Some
of the corresponding coding proteins were briefly labeled at the
bottom of each rectangle. GC vs SG denotes comparison among
the two strains of gastric cancer and the two strains of superficial
gastritis.
Comparison of eight H. pylori strains based on strain specific
genes of six sequenced strains is shown in Figure 4. Twelve large
variable regions are labeled with rectangles, including five red
rectangles denoting predicted gastric cancer strain specific regions
(DR1, 3, 4, 5, 12), three blue rectangles denoting diverse regions
obtained from comparison of gastric cancer strains and superficial
gastritis strains (DR 9, 10, 11), and five green rectangles denoting
common variable genes among all strains (DR 1, 2, 6, 7, 8). These
predicted variable genes based on strain specific genes of the six
sequenced strains were listed in Table 4.
Gene Variation Confirmed by PCR
To further validate the microarray results, we performed PCR
to confirm a predicted 5.2 kb absent region both in gastric cancer
strain HLJ038 and HLJ005 based on the 0–100 kb of the reference
P12 chromosome (Figure 2 A B). PCR results validated that the
5.2 kb region is absent in the two gastric cancer strains but present
in 26695 (data not shown). As shown in Figure 2C, comparing 0–
100 kb of HLJ005 and HLJ038 shows minor differences between
the two GC strains. These scattered differing genes are suspected
to be strain-specific genes of HLJ005 and HLJ038.
A heatmap of variable genes detected among the three H. pylori
test strains was also confirmed using PCR. Green denotes absence
of genes; red indicates presence of genes. The distinct regions of
the three test strains were clustered with a dendrogram, which was
constructed by hierarchical analysis of the presence or absence of
genes. Amplification of some genes showing a weak PCR product
band or a band of incorrect size are represented in black. One
possible explanation for this is that sequence variation in these
genes occurs in the primer binding region. The twenty variable
genes of the TFSS3 and TFSS4 in the eight GC isolates observed
by ADaCGH were confirmed by PCR, showing concordance with
the microarray data. The prevalence of these genes in isolates from
76 additional patients was tested by PCR (Figure 5). These genes
were found to be absent in 18 of 33 GC strains (55%). Other
strains harbor two or more of these gene. These data support the
association of the loss of these genes in isolates from GC patients.
Discussion
In the eight Chinese isolates studied by microarray, we found 14
significant variable regions when comparing GC isolates to SG or
GU isolates based on the P12 reference genome (Figure 3,
Table 2). These regions mainly coded for proteins related to the
type I R-M system (DR3), type II R-M system (DR1), type III R-
M system (DR6, DR12), TFSS system (DR4, DR11), and
hypothetical proteins (DR8). These findings are consistent to
those of previous reports. Previous research found a remarkable
variety of restriction-modification (R-M) systems in H. pylori.
Bacteria utilize R-M systems through conjugative plasmids or
bacteriophages as a defense against invasion by foreign DNA.
Recently, restriction–modification systems have been reported to
be associated with H. pylori virulence. The best understood R-M
system is the type II R-M family. Type II R-M systems include two
enymes: one is a restriction endonuclease which cleaves DNA
within a specific 4–8-bp sequence, while another is a methyltrans-
ferase which can specifically methylate DNA at adenine or
cytosine residues. Bacteria can protect DNA from cleavage
through this mechanism [44–48]. We identified a number of
Figure 4. Comparison of eight H. pylori strains based on strain specific genes of six sequenced strains. Large variable regions were
labeled with colored rectangles. Predicted gastric cancer strain specific regions were labeled with a red rectangle. General genomic variations among
all strains were labeled with a green rectangle. A blue rectangle represents diverse regions obtained from comparison of gastric cancer strains and
superficial gastritis strains. Corresponding coding proteins were briefly labeled at the bottom of each rectangle. GC vs SG denotes comparison
between the two strains of gastric cancer and the two strains of superficial gastritis.
doi:10.1371/journal.pone.0038528.g004
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Strain DR Gene start end Gene description
DR1 HP0440 457297 459330 DNA topoisomerase I (topA)
HP0441 459333 459333 VirB4 homolog
26695 HP0442 461749 462015 hypothetical protein
HP0443 462016 462318 hypothetical protein
strain HP0444 462315 461756 hypothetical protein
HP0445 463954 464139 hypothetical protein
specific DR2 HP0456 475056 475508 hypothetical protein
HP0457 475826 476089 hypothetical protein
genes HP0458 476101 476337 hypothetical protein
HP0459 476337 478913 virB4 homolog (virB4)
HP0460 479043 479531 hypothetical protein
HP0461 479557 479649 hypothetical protein
HP0462 480062 481159 type I restriction enzyme S protein (hsdS)
HP1366 1427688 1428959 type IIS restriction enzyme R protein (MBOIIR)
DR3 HP1367 1428975 1429757 type IIS restriction enzyme M1 protein (mod)
HP1368 1429744 1430607 type IIS restriction enzyme M2 protein (mod)
G27 DR4 1046540 1048216 hypothetical protein
1048432 1048734 hypothetical protein
strain 1053564 1054550 competence protein
1076345 1077382 hypothetical protein
specific 1081055 1082440 hypothetical protein
1082440 1083642 hypothetical protein
genes 1083705 1084781 integrase-recombinase
protein
DR5 1351624 1352001 adenine-specific DNA methylase
1419432 1420331 adenine-specific DNA methylase
HPAG1 DR6 HrgA 94738 95736 HrgA
strain DR7 1410157 1412718 hypothetical protein
Specific genes
J99 DR8 jhp0164 178219 179565 putative restriction enzyme
strain jhp0165 179558 180778 hypothetical protein
Specific genes DR9 jhp0929 1032025 1032477 hypothetical protein
jhp0930 1032591 1032833 hypothetical protein
topA_3 1032846 1034906 topoisomerase I
jhp0932 1034961 1035431 hypothetical protein
jhp0933 1035401 1036204 hypothetical protein
jhp0934 1036277 1037296 hypothetical protein
jhp0935 1037343 1037885 hypothetical protein
jhp0936 1038083 1038616 hypothetical protein
jhp0937 1038613 1039878 hypothetical protein
P12 DR10 virB2-2 1396323 1396607 VirB2 type IV secretion protein
strain virB3-2 1396619 1396882 VirB3 type IV secretion protein
Specific genes 1396894 1397130 hypothetical protein
virB4-2 1397130 1399706 VirB4 type IV secretion ATPase
virB7-2 1399703 1399843 VirB7 type IV secretion protein
virB8-2 1399836 1400972 VirB8 type IV secretion protein
virB9-2 1400969 1402624 VirB9 type IV secretion protein
virB10-2 1402591 1403829 VirB10 type IV secretion protein
1403813 1405597 hypothetical protein
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Strain DR Gene start end Gene description
1405501 1406055 hypothetical protein
1406068 1407030 hypothetical protein
1407047 1407322 hypothetical protein
virB11-3 1407327 1408271 VirB11 type IV secretion ATPase
1408268 1408786 hypothetical protein
virD4-2 1408783 1411026 VirD4 coupling protein
1413163 1413633 hypothetical protein
1413603 1414406 hypothetical protein
1414480 1415145 hypothetical protein
1415123 1415401 hypothetical protein
1415334 1415765 hypothetical protein
1415750 1416160 hypothetical protein
1416165 1416794 hypothetical protein
1416897 1417178 hypothetical protein
1417399 1417788 hypothetical protein
1417796 1418086 hypothetical protein
1418215 1418466 hypothetical protein
1418394 1419248 hypothetical protein
1421131 1421259 hypothetical protein
virD2-2 1421785 1423818 relaxase
DR11 1466136 1466765 hypothetical protein
1470038 1471000 type II R-M system restriction endonuclease
1470981 1471751 type II R-M system restriction endonuclease
1479129 1479917 hypothetical protein
1486667 1487452 hypothetical protein
1487452 1489119 hypothetical protein
1492159 1492494 hypothetical protein
1507434 1507625 hypothetical protein
1524027 1526738 DNA polymerase I
1528042 1530078 type IIS R-M system methyltransferase
1555145 1556065 hypothetical protein
Shi470 DR12 874998 876074 integrase/recombinase (xerD)
strain 876139 877341 hypothetical protein
Specific genes 877341 878726 hypothetical protein
880915 882183 hypothetical protein
882184 883221 hypothetical protein
883375 891786 hypothetical protein
902243 903478 ComB3 protein
906132 908066 topoisomerase I
908059 910557 DNA transfer protein
910570 910830 hypothetical protein
910831 911133 hypothetical protein
911758 913038 hypothetical protein
913049 913813 hypothetical protein
913835 915454 hypothetical protein
Note: DR, different region.
doi:10.1371/journal.pone.0038528.t004
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among the microarray tested strains. The results indicate a strong
correlation between H. pylori R-M system and pathogenesis of
gastric cancer. Further investigations involved in functional
analysis of the R-M system are very necessary to demonstrate
the potential mechanism.
A previous Chinese study, performed by Han, Y. H. et al, also
analyzed the genomic variation of H. pylori isolates from patients
Figure 5. Gene content analysis of TFS4 and TFS3 in eighty-four H. pylori isolates by PCR. The presence of individual genes is indicated in
red, and their absence in green. Non-specific amplicon is shown in black.
doi:10.1371/journal.pone.0038528.g005
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in the H. pylori genome that corresponded to plasticity zones (PZ) 1
and 2. Our results are partially consistent with one diverse region
of their findings. This region comprises genes from HP0424 to
HP0462. However in our study, we only identified genes in these
regions from HP0440 to HP0445 and HP0456 to HP0462. For
diverse region 2 from HP0984 to HP1009, we have not observed
wide variation among our strains except for a minor difference of
HP0993 and HP0994, which are predicted to be absent in GC
strains HLJ005 and HLJ038 compared to the SG strain HLJ220.
In addition to these distinctions, we found the other diverse region
among strains based on 26695 strain specific genes. They are from
HP1366 to HP1368 and encode type IIS restriction enzyme
related proteins. For the other genes that were found by Han, Y.
H. et al, such as HP0447, HP0704, and jhp0918, they claimed
that certain genotypes had higher prevalence of these genes in DU
or GC groups than in CG groups, but this was not inspected in our
microarray that studied eight Heilongjiang province strains. These
discrepancies may be due to the differences in strain selection. It is
also possible that technical differences contribute to the discrep-
ancies observed. Another previous comparative genomic study
reported that genes located in the plasticity zones such as jhp0947
and jhp0949 are associated with disease [49–51]. For these genes,
we also detected a small scattered variable region among the eight
microarray tested strains. But we have not performed PCR tests in
more strains for these genes. In the future, we will follow this work
up with systematic analysis. Despite these variable genes described
above, we found that the cag PAI was significantly conserved in the
eight tested isolates from Heilongjiang province, which is
consistent with the fact that cag PAI is geographically diverse.
The distribution of genes of type-IV secretion systems in
Chinese isolates were also investigated in detail. H. pylori have at
least three type-IV secretion systems (TFSS). The first type IV
secretion system gene cluster is located in the cag pathogenicity
island, which mediates the injection of the toxin CagA and is
thought to be the most important apparatus that contributes to
pathogenesis. Several studies have described and discussed the role
of the cag-pathogenicity island encoded type IV secretion system
in H. pylori pathogenesis [9–11]. However, the potential mecha-
nism for cag PAI induced cancer is still under known. The second
gene cluster is involved in a comB locus that confers competence for
DNA transformation [52]. Recently, a third TFSS responsible for
DNA conjugation has been demonstrated and discussed in various
studies. This TFSS system helps H. pylori rapidly acquire new
genetic features and adapt to changes in the environment [53–56].
We explored genes involving two such TFSS systems of P12 in our
study. Consistent with previous studies, many genes in these
systems are variably present (Figure 5). Although complete TFS3
or TFS4 type IV secretion systems were found in some strains (i.e.,
HLJ242), partial absence of type IV secretion system genes seem to
be more common. None of the tested strains harbored the two
TFSS system genes despite a possible failure to amplify virB7-1. All
of our tested strains did not contain virB7-1; this is probably
because the length of virB7-1 is only 117 bp. Therefore, it is
difficult to design a pair of primers that efficiently amplify this gene
target. Although no significant correlation was found for the
unique absence or presence of TFS4 or TFS3, absence of both
TFS3 and TFS4 system genes displayed significant variation
comparing GC strains to GU, DU, or SG strains (P,0.05). It is
intriguing that large proportions of GC strains in our study lost
these two systems, which are reported to be involved in the
transfer of genomic fragments and the restriction-modification
system through a special mechanism. More thorough research is
required to explore the potential function or mechanism for losing
TFSS systems in GC isolates.
We also found one of the four genes with the 5.2 kb predicted
variable segment, a gene encoding cytosine specific DNA
methyltransferase, is present in 11 of 12 GC strains isolated from
Shandong province (represented as YTC). This suggests that
special genomic characteristics may exist in this group of strains.
Based on the strain specific genes of the six sequenced genomes,
several variable genes were identified including an hrgA gene
(Figure 4, Table 3, DR6), which has been previously reported to
be a strain-specific gene that might be associated with gastric
cancer among H. pylori isolates from Asian patients [57]. For the
distribution of hrgA in our 33 tested gastric cancer strains, 25 (76%)
tested positive for the presence of this gene, which was higher than
previously reported rates of prevalence (43%). 21 of the remaining
51 (41%) isolates of non-cancer patients were positive for the gene.
There is no statistical significance for the distribution of hrgA in
different diseases (Table 5). There are many additional variable
genes that were screened by microarray among the tested strains.
Validating each of these genes one by one by PCR would be
laborious and be contrary to the goals of a microarray-based
experiment, which is rapid and high throughput genomic analysis.
Since the custom HP 90 k tiling microarray has been well
designed, established, and evaluated in this study, a greater
number of strains need to be analyzed by this tool in order to
gather more detailed and reliable information about which
variable genes contribute to different disease status.
We initially tried to cover all sequenced strains for probe design.
At the time, only six strains had completed genome maps online.
P12 was selected as a major tiling reference sequence since it is the
longest. Strain specific genes of an additional five strains were also
tiled to search for possible differences among the tested strains. To
quickly evaluate the accuracy of this array design, we initially
hybridized a well known sequenced strain 26695 and two strains
isolated from two gastric cancer patients in Heilongjiang province.
Paired comparison of these strains for a 0–100 kb region based on
the P12 reference genome revealed several regions with genetic
variation. Specific primers were designed for these genes, and
PCR validation was performed in 26695, HLJ005, and HLJ038.
Of the 12 genes tested, 11 were consistent with the microarray
prediction(data not shown). For the strain specific genes of the six
sequenced strains, our results precisely predicted that all strain
specific genes of 26695 are actually present in 26695 compared to
HLJ005 and HLJ038. These results indicate that the designed
Table 5. Distribution of hrgA in different diseases.
Diseases hrgA Total
+ 2
GC 25 8 33
G U 527
D U 448
GDU 0 4 4
SG 9 14 23
A G 123
F D 336
Total 47 37 84
Note: GC, gastric cancer. GU, gastric ulcer. AG, atrophic gastritis, DU, duodenal
ulcer GDU, gastroduodenal ulcer, FD, functional dyspepsia, SG, non-atrophic
gastritis.
doi:10.1371/journal.pone.0038528.t005
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diversity among different HP strains.
The aim of this study was to search for genomic characteristics
that may contribute to various digestive diseases. Strain selection is
one of the most important aspects of this study because genomic
diversity exists among strains of different geographic origin. To
eliminate this interference, we selected eight strains that originated
from a northeast province of China. Heilongjiang province has
one of the highest incidence rates of gastric cancer. Our results
show that comparison of the strains with the same diseases
(HLJ005 vs HLJ038) have less variation than the strains with
different diseases, which indicates that it is reasonable to further
investigate more paired strains with different clinical diseases.
With the rapid development of next generation sequencing
technology and reduced costs, microarrays will be completely
replaced by sequencing in the future. However, no one can predict
how long this change will take. We believe, that because of its low
cost, microarray technology will continue to play an important
role in genomic and expression level analyses of bacterial
pathogens for several years. It also has easy handling and rapid
time saving advantages. The established in situ synthesized high
density oligo tiling microarray was successfully utilized in this study
and can be used as a high throughput analytic tool for comparative
genomics of H. pylori. Results of our study promote further
understanding of specific disease-associated genes that can serve as
novel biomarkers for identification of gastroduodenal diseases.
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